News summary
Shengnuo Pharmaceuticals-B(02257rubyslots$100nodepositbonus.HK) Chief Strategy Officer Dai Xiaochang resigned on May 17 due to private reasonsrubyslots$100nodepositbonus, but remains as executive directorrubyslots$100nodepositbonus, and appointed as a senior consultant for drug development and commercialization of the group.
Newsletter text
[Dai Xiaochang, chief strategy officer of Shengnuo Pharmaceutical, leaves office] On May 17, Shengnuo Pharmaceutical (stock code: 02257rubyslots$100nodepositbonus.HK) issued an announcement stating that Dai Xiaochang decided to resign as chief strategy officer due to personal reasons, and the decision will take effect from the day of the announcement.
Dai Xiaochang continued to serve as executive director and agreed to become a senior consultant for the group's drug development and commercialization. This move is regarded as another important measure by the company in strategic adjustment and talent layout.
